20 Stocks Moving In Monday's Pre-Market Session

Gainers

• Westport Fuel Systems Inc (USA) (NASDAQ: WPRT) rose 34 percent to $1.42 in pre-market trading after the company reported the signing of a definitive agreement to sell its APU assets for $70 million.
• Alere Inc (NYSE: ALR) rose 17 percent to $49.50 in pre-market trading. Abbott Laboratories (NYSE: ABT) agreed to buy Alere for $51 per share, versus its earlier offer of $56 per share.
• Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares rose 16.5 percent to $2.97 in pre-market trading after declining 2.67 percent on Thursday.
• HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 11.9 percent to $6.50 in pre-market trading on announcement that the company and Daiichi Sankyo have completed a master services agreement.
• Catalyst Biosciences Inc (NASDAQ: CBIO) rose 10.2 percent to $5.96 in pre-market trading after climbing 2.46 percent on Thursday.
• Moneygram International Inc (NASDAQ: MGI) rose 9.1 percent to $18.00 in pre-market trading after China's Ant Financial raised its bid for the company by 36 percent to $18 per share in cash.
• Cameco Corp (USA) (NYSE: CCJ) rose 7.1 percent to $11.90 in pre-market trading after dropping 1.94 percent on Thursday.
• Straight Path Communications Inc (NYSE: STRP) rose 7 percent to $98.10 in pre-market trading after falling 0.33 percent on Thursday. A report on Thursday mentioned that Verizon could top AT&T bid.
• Norsat International Inc (USA) (NYSE: NSAT) shares rose 6.4 percent to $10.75 in pre-market trading. Privet Fund Management offered US$11 per share to acquire Norsat International.
• Pingtan Marine Enterprise Ltd (NASDAQ: PME) shares rose 5.4 percent to $4.90 in pre-market trading after gaining 5.92 percent on Thursday.
• Nutanix Inc (NASDAQ: NTNX) rose 4.6 percent to $18.00 in pre-market trading after dropping 2.71 percent on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• GWG Holdings Inc (NASDAQ: GWGH) fell 19.4 percent to $8.45 in pre-market trading after dropping 5.62 percent on Thursday.
• Incyte Corporation (NASDAQ: INCY) fell 10.9 percent to $125.50 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Co and Incyte arthritis drug Olumiant. PiperJaffray downgraded Incyte from Overweight to Neutral.
• Baxter International Inc (NYSE: BAX) shares fell 9.9 percent to $48.00 in the pre-market trading session. Baxter disclosed that one of its employees received a DoJ grand jury subpoena pursuant to criminal investigation.
• Patheon NV (NYSE: PTHN) fell 9.8 percent to $23.26 in pre-market trading after dropping 1.04 percent on Thursday.
• Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) fell 8.3 percent to $14.68 in pre-market trading. Chardan Capital reiterated Akari Therapeutics with a Sell and raised the price target from $5.00 to $6.50.
• RH (NYSE: RH) shares fell 6.3 percent to $44.05 in pre-market trading after slipping 0.02 percent on Thursday.
• SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) shares fell 5.7 percent to $9.05 in pre-market trading after dropping 1.03 percent on Thursday.
• Eli Lilly and Co (NYSE: LLY) fell 5.2 percent to $81.41 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Incyte arthritis drug Olumiant. BMO Capital downgraded Eli Lilly from Market Perform to Underperform.
• Texas Pacific Land Trust (NYSE: TPL) dropped 5.2 percent to $263.50 in pre-market trading after declining 5.91 percent on Thursday.